Christina Price, MD
Associate Professor of Medicine (Allergy & Immunology)DownloadHi-Res Photo
Cards
Appointments
Allergy & Immunology
Primary
Additional Titles
Clinical Chief of Allergy and Immunology, Rheumatology, Allergy, & Immunology
VA Medical Center Section Chief, Allergy and Clinical Immunology, VA Medical Center
Contact Info
Allergy & Immunology
PO Box 208013
New Haven, CT 06520-8013
United States
Appointments
Allergy & Immunology
Primary
Additional Titles
Clinical Chief of Allergy and Immunology, Rheumatology, Allergy, & Immunology
VA Medical Center Section Chief, Allergy and Clinical Immunology, VA Medical Center
Contact Info
Allergy & Immunology
PO Box 208013
New Haven, CT 06520-8013
United States
Appointments
Allergy & Immunology
Primary
Additional Titles
Clinical Chief of Allergy and Immunology, Rheumatology, Allergy, & Immunology
VA Medical Center Section Chief, Allergy and Clinical Immunology, VA Medical Center
Contact Info
Allergy & Immunology
PO Box 208013
New Haven, CT 06520-8013
United States
About
Titles
Associate Professor of Medicine (Allergy & Immunology)
Clinical Chief of Allergy and Immunology, Rheumatology, Allergy, & Immunology
Positions outside Yale
VA Medical Center Section Chief, Allergy and Clinical Immunology, VA Medical Center
Biography
Christina Price, MD is a board certified allergist and clinical immunologist who treats a wide range of conditions.
As Associate Professor of Medicine at Yale School of Medicine and the Chief of Allergy & Immunology at the West Haven VA, Dr. Price has a particular expertise in patients with immune deficiency and immune dysregulation. Patients with autoimmune disease who require immune suppression are managed with their specialists in a team approach. She has collaborated with Smilow Cancer Center to provide immunology services to patients receiving immunotherapy and leads the immunotoxicity conference and Smilow Immunology Clinic.
Appointments
Allergy & Immunology
Associate Professor on TermPrimary
Other Departments & Organizations
- Allergy & Immunology
- Internal Medicine
- Primary Immunodeficiency Program
- Rheumatology, Allergy, & Immunology
- Yale Medicine
Education & Training
- Fellow
- Yale University (2012)
- Chief Resident
- Yale University Bridgeport Hospital (2009)
- Residency
- Yale University Bridgeport Hospital (2008)
- Post Doctoral Fellowship
- Johns Hopkins University (2006)
- Internship
- Boston Medical Center- Boston University (2004)
- MD
- Saint Louis University School of Medicine (2003)
- BA
- Saint Louis University, Economics, Biology (1999)
Research
Research at a Glance
Yale Co-Authors
Frequent collaborators of Christina Price's published research.
Publications Timeline
A big-picture view of Christina Price's research output by year.
Kelsey Kaman, MD, BSN
Clemente Britto-Leon, MD
Alfred Lee, MD, PhD
Astha Chichra, MBBS
Christine Won, MD, MSc, BA
Frederick Lewis Altice, MD, MA
20Publications
784Citations
Publications
2022
Management of Steroid-Refractory Gastrointestinal Immune-Related Adverse Events
Brongiel S, Rychalsky K, Luon D, Johnson A, Price C, Abdelghany O. Management of Steroid-Refractory Gastrointestinal Immune-Related Adverse Events. Annals Of Pharmacotherapy 2022, 57: 148-155. PMID: 35656843, DOI: 10.1177/10600280221094330.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsImmune checkpoint inhibitorsInstitutional review boardImmunosuppressive therapyAdverse eventsSymptom resolutionImmune-related adverse eventsSecond-line immunosuppressive therapyRetrospective medical record reviewSecond-line medicationsCommon Terminology CriteriaSecond-line therapySecond-line treatmentMedical record reviewDose of infliximabHigh response rateUniversity Institutional Review BoardGastrointestinal ImmuneIrAE treatmentSteroid failureTerminology CriteriaCheckpoint inhibitorsMost patientsRecord reviewInclusion criteriaPatients
2021
Severe breakthrough COVID-19 cases in the SARS-CoV-2 delta (B.1.617.2) variant era
Wang SY, Juthani PV, Borges KA, Shallow MK, Gupta A, Price C, Won CH, Chun HJ. Severe breakthrough COVID-19 cases in the SARS-CoV-2 delta (B.1.617.2) variant era. The Lancet Microbe 2021, 3: e4-e5. PMID: 34901896, PMCID: PMC8641954, DOI: 10.1016/s2666-5247(21)00306-2.Peer-Reviewed Original ResearchCitationsAltmetricMeSH KeywordsSafety Evaluation of the Second Dose of Messenger RNA COVID-19 Vaccines in Patients With Immediate Reactions to the First Dose
Krantz MS, Kwah JH, Stone CA, Phillips EJ, Ortega G, Banerji A, Blumenthal KG. Safety Evaluation of the Second Dose of Messenger RNA COVID-19 Vaccines in Patients With Immediate Reactions to the First Dose. JAMA Internal Medicine 2021, 181: 1530-1533. PMID: 34309623, PMCID: PMC8314170, DOI: 10.1001/jamainternmed.2021.3779.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsCytokine profiles in severe SARS-CoV-2 infection requiring extracorporeal membrane oxygenation support
Kaman K, Azmy V, Chichra A, Britto-Leon C, Price C. Cytokine profiles in severe SARS-CoV-2 infection requiring extracorporeal membrane oxygenation support. Respiratory Medicine Case Reports 2021, 33: 101376. PMID: 33680800, PMCID: PMC7925237, DOI: 10.1016/j.rmcr.2021.101376.Peer-Reviewed Original ResearchCitationsConceptsExtracorporeal membrane oxygenation supportMembrane oxygenation supportVV-ECMOOxygenation supportCytokine stormVeno-venous extracorporeal membrane oxygenation supportSevere SARS-CoV-2 infectionSARS-CoV-2 infectionVV-ECMO supportRefractory respiratory failureProspective cohort studyCohort of patientsInterleukin-2 receptorCytokine elevationHyperinflammatory stateECMO supportRespiratory failureCohort studyCytokine profileClinical courseInterleukin-10COVID19 patientsUnderlying pathophysiologyInterleukin-6Inflammatory responseAllergy & Immunology Involvement on Multidisciplinary Treatment Team During COVID-19 Pandemic
Azmy V, Kaman K, Price C. Allergy & Immunology Involvement on Multidisciplinary Treatment Team During COVID-19 Pandemic. Journal Of Allergy And Clinical Immunology 2021, 147: ab114. PMCID: PMC7849596, DOI: 10.1016/j.jaci.2020.12.418.Peer-Reviewed Original ResearchCytokine Profiles Before and After Immune Modulation in Hospitalized Patients with COVID-19
Azmy V, Kaman K, Tang D, Zhao H, Dela Cruz C, Topal JE, Malinis M, Price CC. Cytokine Profiles Before and After Immune Modulation in Hospitalized Patients with COVID-19. Journal Of Clinical Immunology 2021, 41: 738-747. PMID: 33459964, PMCID: PMC7812117, DOI: 10.1007/s10875-020-00949-6.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsMeSH KeywordsAdultAgedAged, 80 and overAntibodies, Monoclonal, HumanizedBiomarkersCOVID-19COVID-19 Drug TreatmentCytokine Release SyndromeCytokinesDrug Therapy, CombinationFeasibility StudiesFemaleGlucocorticoidsHospitalizationHumansImmunologic FactorsMaleMiddle AgedRetrospective StudiesSARS-CoV-2Severity of Illness IndexTreatment OutcomeYoung AdultConceptsIL-10 levelsIL-6IL-10Disease severityCytokine profileD-dimerTreatment algorithmCritical SARS-CoV-2 infectionCOVID-19SARS-CoV-2 infectionAdministration of tocilizumabAdmission IL-6Maximum oxygen requirementsTocilizumab-treated patientsElevated IL-6Immune-modulating therapyCritical COVID-19Retrospective chart reviewTertiary care centerIL-6 levelsMean IL-6IL-6 inhibitionAdministration of glucocorticoidsRole of cytokinesCytokine elevation
2020
Overview on the use of IL-6 agents in the treatment of patients with cytokine release syndrome (CRS) and pneumonitis related to COVID-19 disease
Zhou Z, Price CC. Overview on the use of IL-6 agents in the treatment of patients with cytokine release syndrome (CRS) and pneumonitis related to COVID-19 disease. Expert Opinion On Investigational Drugs 2020, 29: 1407-1412. PMID: 33094669, DOI: 10.1080/13543784.2020.1840549.BooksCitationsMeSH Keywords and ConceptsConceptsCytokine release syndromeIL-6 inhibitorsRelease syndromeSafety profileInterleukin-6Mild safety profileRandomized clinical trialsTreatment of patientsAvailable clinical dataCOVID-19COVID-19 diseaseCOVID-19 managementNovel coronavirus pneumoniaHyperinflammatory stateClinical outcomesHealthcare burdenClinical trialsClinical dataObservational studyImmune responseLong-term effectsClinical reportsLiterature searchCoronavirus pneumoniaTocilizumabOptimizing Care for Patients With Adverse Events From Immunotherapeutics.
Sheehan K, Price C, Hafez N. Optimizing Care for Patients With Adverse Events From Immunotherapeutics. The Cancer Journal 2020, 26: 537-542. PMID: 33298725, DOI: 10.1097/ppo.0000000000000492.BooksMeSH Keywords and ConceptsConceptsImmune checkpoint inhibitorsAdverse eventsCheckpoint inhibitorsImmune therapyGuideline-driven managementMajority of irAEsSteroid-refractory casesRisk patientsOptimal carePredictive biomarkersTumor boardIrAEsWellness clinicPatientsEarly detectionTranslational researchTherapyCareCommon occurrenceInhibitorsImmunotherapeuticsClinicSteroidsImmuneBiomarkersTocilizumab Treatment for Cytokine Release Syndrome in Hospitalized Patients With Coronavirus Disease 2019 Survival and Clinical Outcomes
Price CC, Altice FL, Shyr Y, Koff A, Pischel L, Goshua G, Azar MM, Mcmanus D, Chen SC, Gleeson SE, Britto CJ, Azmy V, Kaman K, Gaston DC, Davis M, Burrello T, Harris Z, Villanueva MS, Aoun-Barakat L, Kang I, Seropian S, Chupp G, Bucala R, Kaminski N, Lee AI, LoRusso PM, Topal JE, Dela Cruz C, Malinis M. Tocilizumab Treatment for Cytokine Release Syndrome in Hospitalized Patients With Coronavirus Disease 2019 Survival and Clinical Outcomes. CHEST Journal 2020, 158: 1397-1408. PMID: 32553536, PMCID: PMC7831876, DOI: 10.1016/j.chest.2020.06.006.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsCytokine release syndromeTocilizumab-treated patientsSevere diseaseRelease syndromeTocilizumab treatmentInflammatory biomarkersNonsevere diseaseSoluble IL-2 receptor levelsHigh-sensitivity C-reactive proteinIL-2 receptor levelsConsecutive COVID-19 patientsIL-6 receptor antagonistMechanical ventilation outcomesC-reactive proteinCOVID-19 patientsHigher admission levelsRace/ethnicityMV daysVentilation outcomesAdverse eventsChart reviewClinical responseMedian ageWhite patientsClinical outcomesRepurposing antimicrobial stewardship tools in the electronic medical record for the management of COVID-19 patients
Davis MW, McManus D, Koff A, Jaszczur GR, Malinis M, Dela Cruz C, Britto CJ, Price C, Azmy V, Kaman K, Gaston D, Early K, DeWitt M, Song JS, Ortiz C, Juthani-Mehta M, Topal JE. Repurposing antimicrobial stewardship tools in the electronic medical record for the management of COVID-19 patients. Infection Control And Hospital Epidemiology 2020, 41: 1335-1337. PMID: 32507113, PMCID: PMC7308631, DOI: 10.1017/ice.2020.281.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and Concepts
Academic Achievements & Community Involvement
activity Arthritis and Rheumatism
Journal ServiceReviewerDetails2013 - Presentactivity Oncology
Journal ServiceReviewerDetails2018 - Presentactivity LINC (Leadership, Innovation, Collaboration) Advisory Board
Advisory BoardsMemberDetailsGrifolsAdvisory Board member to Grifols regarding IgG replacement therapy use, major obstacles in the field, research initiatives and future directions2015 - Presentactivity American Academy of Allergy Asthma and Immunology
Professional OrganizationsCommittee MemberDetailsAAAAI Veterans Health Administration Allergists Committee member representing the West Haven VA2013 - Presentactivity American Academy of Allergy Asthma and Immunology
Professional OrganizationsMemberDetailsBasic and Clinical Immunology Interest Section2011 - Present
Clinical Care
Overview
Christina Price, MD, is an allergist and clinical immunologist who treats patients with immune deficiencies and immune dysregulation. Dr. Price serves as the clinical chief of Allergy and Immunology. She is also chief of Allergy and Immunology at the VA Connecticut Healthcare System in West Haven.
Dr. Price comes from a family of healthcare providers and says she has long been drawn to the complexities and potential of the human immune system. In addition to her clinical work, she researches immunotherapy to treat cancer and helped launch an immunology clinic at Smilow Cancer Hospital.
Dr. Price is an associate professor of medicine (allergy and immunology) at Yale School of Medicine.
Clinical Specialties
Allergy & Clinical Immunology; Pediatric Allergy & Immunology
Fact Sheets
Seasonal Allergies (Allergic Rhinitis)
Learn More on Yale MedicineVitamin D Deficiency
Learn More on Yale MedicinePediatric Cancer Immunotherapy
Learn More on Yale MedicineMultisystem Inflammatory Syndrome in Children (MIS-C)
Learn More on Yale Medicine
Yale Medicine News
Are You a Patient?
View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.
View Doctor ProfileNews
News
- September 20, 2022
Ad Hoc Treatment Team Develops COVID Guidelines
- July 27, 2022
New Appointments & Promotions Within Department of Internal Medicine
- March 17, 2022
Discoveries & Impact (March 2022)
- September 10, 2021
Vaccines Highly Effective, But Breakthrough Infections Can Occur
Get In Touch
Contacts
Appointment Number
Clinic Fax Number
Mailing Address
Allergy & Immunology
PO Box 208013
New Haven, CT 06520-8013
United States
Locations
Patient Care Locations
Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.